COPD
Featured Article
Michael Cawley, PharmD, discusses a recently approved digitized respiratory inhaler and explains why health care providers should consider how this new technology will track personal data.
“The use of fixed-dose and free combination triple therapy in patient populations outside of those recommended in guidelines may unnecessarily increase the risks and costs of COPD treatment,”…
“Effective care management for IPF should aim to improve health outcomes and reduce hospital costs,” researchers advised, “which may be achieved by the maintenance of lung function.”